Drug Profile


Alternative Names: Hyprim; RO 10-5970; Unitrim

Latest Information Update: 15 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Antibacterials; Diaminopyrimidines
  • Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Bacterial infections
  • Market Withdrawal Cancer; Respiratory tract infections

Most Recent Events

  • 15 Aug 2007 Discontinued - Phase-I for Bacterial infections in Japan (PO)
  • 15 Aug 2007 Discontinued - Phase-III for Bacterial infections in Belgium (PO)
  • 15 Aug 2007 Discontinued - Phase-III for Bacterial infections in Germany (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top